DEBx Medical has secured a second round of investment from TVM Capital Healthcare to accelerate its global expansion in chronic wound care, particularly with its innovative product DEBRICHEM®, which effectively eliminates biofilm and infection. This funding will enhance commercialization efforts and support the company's mission to improve patient outcomes in highly regulated markets. With CE and ISO certifications, DEBRICHEM® has already shown success in Europe and parts of the MENA region, aiming to transform chronic wound management worldwide.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
